An Institutional Policy on the Right to Benefit from the Commercialization of Human Biological Material

, , &
Journal of Law, Medicine and Ethics 18 (1-2):162-167 (1990)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.1990.tb01144.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,963

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

An Institutional Policy on the Right to Benefit from the Commercialization of Human Biological Material.Ernest D. Prentice, John C. Wiltse, John G. Sharp & Dean L. Antonson - 1990 - Journal of Law, Medicine and Ethics 18 (1-2):162-167.
Different types—different rights.Barbro Björkman - 2007 - Science and Engineering Ethics 13 (2):221-233.
Institutional Entrepreneurs as Political Actors.Richard Windischhofer & Mika Skippari - 2008 - Proceedings of the International Association for Business and Society 19:410-420.
Managing Human Tissue Transfer Across National Boundaries – An Approach from an Institution in South Africa.Safia Mahomed, Kevin Behrens, Melodie Slabbert & Ian Sanne - 2015 - Developing World Bioethics 16 (1):29-35.
The commercialization of university-based research: Balancing risks and benefits.Timothy Caulfield & Ubaka Ogbogu - 2015 - BMC Medical Ethics 16 (1):1-7.
We’re not in it for the money—lay people’s moral intuitions on commercial use of ‘their’ biobank.Kristin Solum Steinsbekk, Lars Øystein Ursin, John-Arne Skolbekken & Berge Solberg - 2013 - Medicine, Health Care and Philosophy 16 (2):151-162.
Donating Human Samples: Who Benefits? – Cases from Iceland, Kenya, and Indonesia.J. Lucas, D. Schroeder, G. Arnason, P. Andanda, J. Kimani, V. Fournier & M. Krishnamurthy - 2013 - In D. Schroeder & J. Lucas (eds.), Benefit Sharing – From Biodiversity to Human Genetics. Springer.
Compositional & Functional Matter: Aristotle on the Material Cause of Biological Organisms.Christopher Byrne - 2015 - Apeiron 48 (4):387-406.
Individual and institutional conflict of interest: Policy review by research universities in the united states.Nils Hasselmo - 2002 - Science and Engineering Ethics 8 (3):421-427.
Equitable Access to Human Biological Resources in Developing Countries: Benefit Sharing Without Undue Inducement.Roger Scarlin Chennells - 2015 - Cham: Imprint: Springer.
Benefit-sharing: an inquiry regarding the meaning and limits of the concept in human genetic research.Kadri Simm - 2005 - Genomics, Society and Policy 1 (2):1-12.
Making the Social World: The Structure of Human Civilization.John R. Searle (ed.) - 2009 - , US: Oxford University Press.
Policy metrics under scrutiny : the legacy of new public management.Daniel Tarschys - 2010 - In Hans Joas (ed.), The benefit of broad horizons: intellectual and institutional preconditions for a global social science: festschrift for Bjorn Wittrock on the occasion of his 65th birthday. Leiden [etc.]: Brill. pp. 24--33.
A Role for Research Ethics Committees in Exchanges of Human Biospecimens Through Material Transfer Agreements.Donald Chalmers, Dianne Nicol, Pilar Nicolás & Nikolajs Zeps - 2014 - Journal of Bioethical Inquiry 11 (3):301-306.
Defining 'Markets' for Pharmaceuticals in Sweden: Public Policy and Commercialization. [REVIEW]Ebba Sjögren - 2007 - Minerva 45 (2):161-173.

Analytics

Added to PP
2016-02-04

Downloads
14 (#991,344)

6 months
1 (#1,472,961)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

At Law: Who's Afraid of the Human Genome?George J. Annas - 1989 - Hastings Center Report 19 (4):19.
Of Morals, Markets, and Medicine.Gordon Bermant, Peter Brown & Gerald Dworkin - 1975 - Hastings Center Report 5 (1):14-16.

View all 6 references / Add more references